PT-141 Peptide Vial (Bremelanotide)

Description

This product is intended for research purposes only. To be used by trained research professionals only.

PT-141, also known as Bremelanotide, is a synthetic peptide that has shown promise on improving sexual function. Derived from the Melanotan II peptide, PT-141 is notable for its unique way of working: unlike Viagra, it does not work on the vascular system but activates melanocortin receptors in the central nervous system to boost sexual arousal and desire.

Studies have shown that it can be effective as a melanocortin receptor agonist for both men and women facing sexual dysfunction. In men, it has the potential to improve erectile function by enhancing blood flow to the penis. In women, it has been found to positively affect sexual response and increase desire, particularly in premenopausal women who struggle with sexual satisfaction.

Bremelanotide is usually given through subcutaneous injections, providing targeted relief for those with hypoactive sexual desire disorder. Its ability to engage the body’s natural mechanisms makes it a promising option for enhancing sexual health and intimacy for both sexes.

Key Features of PT-141 Peptide Vial 10mg

Vial Material and Design: Made from high-quality glass, each vial is designed to ensure optimal preservation of the peptide’s integrity against environmental factors like light and temperature.

Peptide Purity: The PT-141 Peptide Vial 10mg boasts a purity level of 99%, a critical factor in ensuring reliable research outcomes and minimizing any extraneous variables or contaminants.

Dosage Form: Available in a concentrated 10mg vial to facilitate various scales of research and experimental requirements.

Complete Kits: The vials can be purchased as a complete kit, which includes bacteriostatic water and syringes, simplifying the processes of reconstitution and administration.

Potential Benefits:Research has demonstrated promising results in enhancing sexual desire and function for both healthy males and women. The PT-141 peptide vial 10mg is administered through targeted subcutaneous injections and has been found to be an effective treatment for hypoactive sexual desire disorder. Studies indicate significant improvements in erectile function, particularly relating to penile erection, and increased sex drive.

Moreover, many women report enhanced intimacy and greater satisfaction during intimate experiences. Notably, these benefits are observed in premenopausal women experiencing sexual dysfunction, highlighting its potential for improving overall sexual health and satisfaction.